Wolf Blitzer looks at politics, breaking news and international stories. Undoubtedly, hes going to confirm all the suspicions mounting for the past year that hes been using his chairmanship to protect the president. We recall last year when he viewed some things he viewed as problematic in those intelligence reports. He rushed to the white house, briefed the president about it before even briefing his committee. He was forced to step aside from the Russia Investigation on his Committee Last year, but he still wielded considerable influence from the outside. He stopped democratic attempts to subpoena witnesses, to get more records, to schedule witness interviews. Behind the scenes, he mounted his own investigation to try to sew doubt on the fbi, the Russia Investigation, the mueller probe. That led to the release of the nunes memo from earlier this year, criticizing how that fisa warrant was obtained to monitor carter page. Democrats say this is all part of this effort by devin nunes to
Post-hoc analyses from four phase III studies indicate Vabysmo dried retinal fluid faster with fewer injections in neovascular or ‘wet’ age-related macular degeneration and diabetic. | April 25, 2023
SOUTH SAN FRANCISCO (dpa-AFX) - Roche (RHHBY) reported two-year data from the TENAYA and LUCERNE studies that reinforce the long-term efficacy, safety and durability of Vabysmo (faricimab) in neovascular
In the TENAYA and LUCERNE studies, more than 60% of Vabysmo patients could be treated every four months at two years. This represents an increase from 45% at year one Patients treated with Vabysmo received
Susvimo, previously called Port Delivery System with ranibizumab, is the first nAMD treatment in 15 years to provide an alternative to standard-of-care eye injections needed as often as once a monthBy